Live Harder
- Sep 15, 2021
- 1 min read

Neuraly Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 2B Trial

https://www.businesswire.com/news/home/20201102005054/en/Neuraly-Receives-FDA-Clearance-of-Investiga

Recent Posts

Fibroblast growth factor 1 (FGF-1) to possibly treat Parkinson's Disease

https://l.facebook.com/l.php?u=https%3A%2F%2Fwww.pd-studies.com%2F%3Fmibextid%3DZxz2cZ%26fbclid%3DIwAR27vhRZpwK1dhqVX2clQRnTmpp7xGVKM16XCh7HhZEWifSywHGaW5NinSk&h=AT2TwT8tHzXxSYJFw77-LRdIGRj4FeOTUpdHNw

Common Bacteria Could Be The Main Cause of Parkinson's Disease

https://l.facebook.com/l.php?u=https%3A%2F%2Fwww.iflscience.com%2Fcommon-bacteria-could-be-the-main-cause-of-parkinsons-disease-68821%3Ffbclid%3DIwAR2hLj7YSJwpv-3q5ADBdHbfQSQ9sBy-aOOKCHhmk9f6Mr6jZk-2T

Artificial Intelligence study and Parkinson's

https://www.parkinson.org/blog/science-news/artificial-intelligence